FIELD: medicine.
SUBSTANCE: in blood of patients with chronic obstructive lung disease defined are content of CD3+ CD16-, IgE, spontaneous proliferation of T-lymphocytes (activated cells), percent of lymphocytes with increased quantity of DNA (G1-phase), phagocytic index, stimulated by zymosan test with nitro-blue tetrazolium (NBT- induced) is carried out. If values of CD3+ CD16- content are over 1.85·103, IgE over 330 IU/ml, of spontaneous proliferation less than 20%, percent of lymphocytes with increased DNA (G1-phase) quantity less than 1.9 phagocytic index over 52, stimulated by zymosan test with nitro-blue tetrazolium over 38% lung cancer development is predicted.
EFFECT: application of claimed method allows to predict development of disease accurately.
2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE OF ROUND PULMONARY SHADOWS IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2009 |
|
RU2400149C1 |
| METHOD OF PREDICTING DEVELOPMENT OF LUNG ABSCESS IN CASE OF CHRONIC OBSTRUCTIVE LUNG DISEASE | 2009 |
|
RU2407010C1 |
| METHOD FOR DETERMINING THE INDIVIDUAL RISK OF FORMING SQUAMOUS CELL LUNG CANCER BASED ON THE ANALYSIS OF THE SPUTUM MICROBIOME | 2020 |
|
RU2771855C2 |
| METHOD OF PREDICTING BEGINNING OF CHRONIC OBSTRUCTIVE LUNG DISEASE | 2009 |
|
RU2407012C1 |
| METHOD OF TREATMENT OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2006 |
|
RU2323728C2 |
| METHOD OF ENHANCING NONSPECIFIC PROTECTION FACTORS ACTIVITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2015 |
|
RU2600838C1 |
| METHOD FOR PREDICTION OF STAGE OF MULTIPLE SCLEROSIS TAKING INTO ACCOUNT VALUES OF IMMUNOLOGICAL STATUS | 2013 |
|
RU2528882C1 |
| METHOD FOR PREDICTION OF DEVELOPING MULTIPLE SCLEROSIS TAKING INTO ACCOUNT IMMUNE-METABOLIC VALUES | 2013 |
|
RU2528879C1 |
| WAY OF LOCAL IMMUNOTHERAPY OF SEPTIC WOUNDS OF MAXILLOFACIAL AREA | 2007 |
|
RU2361626C2 |
| METHOD FOR IMMUNOREHABILITATION IN PATIENTS WITH CHRONIC BRONCHITIS | 2002 |
|
RU2222336C2 |
